Induction of T lymphocyte apoptosis by sulphasalazine in patients with Crohn's disease

Gut

Volumn 53, Issue 11, 2004, Pages 1632-1638

  Doering, J ^a,b   Begue, B ^a   Lentze, M J ^b   Rieux Laucat, F ^a   Goulet, O ^a   Schmitz, J ^a   Cerf Bensussan, N ^a   Ruemmele, F M ^a,b  

^a INSERM   (France)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CASPASE 3; CASPASE 9; COLLAGENASE; EGTAZIC ACID; FAS ANTIGEN; FAS LIGAND; INHIBITOR OF APOPTOSIS PROTEIN; LIPOCORTIN 5; MESALAZINE; PROPIDIUM IODIDE; PROTEIN BCL 2; PROTEIN BCL XL; SALAZOSULFAPYRIDINE; SULFAPYRIDINE;

ADOLESCENT; APOPTOSIS; ARTICLE; CENTRIFUGATION; CHILD; CONTROLLED STUDY; CROHN DISEASE; DOWN REGULATION; DRUG POTENCY; ENZYME ACTIVATION; ENZYME ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INTESTINE MUCOSA; LAMINA PROPRIA; MITOCHONDRION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ULCERATIVE COLITIS; WESTERN BLOTTING; WILD TYPE;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; CROHN DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNITY, MUCOSAL; INTESTINAL MUCOSA; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MESALAMINE; SULFAPYRIDINE; SULFASALAZINE; T-LYMPHOCYTES;

EID: 7244223147     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2003.037911     Document Type: Article

References (33)

1. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998;115:182-205.
2. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417-29.
3. Shanahan F. Crohn's disease. Lancet 2002;359:62-9.
4. Levine AD. Apoptosis: Implications for inflammatory bowel disease. IBD 2000;6:191-205.
5. Ina K, Itoh J, Fukushima K, et al. Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance. J Immunol 1999;163:1081-90.
6. Boirivant M, Marini M, Di Felice G, et al. Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis. Gastroenterology 1999;116:557-65.
7. Itah J, de La Motte C, Strong SA, et al. Decreased Bax expression by mucosal T cells favours resistance to apoptosis in Crohn's disease. Gut 2001;49:35-41.
8. Atreya R, Mudter J, Finotto S, et al. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn's disease and experimental colitis in vivo. Nat Med 2000;6:583-8.
9. Nagata S. Apoptosis by death factor. Cell 1997;88:355-65.
10. Nagata S, Golstein P. The Fas death factor. Science 1995;267:1449-56.
11. Green DR. Apoptotic pathways: the roads to ruin. Cell 1998;94:695-8.
12. Goyal L. Cell death inhibition: keeping casposes in check. Cell 2001;104:805-8.
13. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998;281:1309-12.
14. Wahl C, Liptay S, Adler G, et al. Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J Clin Invest 1998;101:1163-74.
15. Kaiser GC, Van F, Polk DB. Mesalamine blocks tumor necrosis factor growth inhibition and nuclear factor kappaB activation in mouse colonocytes. Gastroenterology 1999;116:602-9.
16. Kreuz S, Siegmund D, Scheurich P, et al. NF-kappaB inducers upregulate cFLIP, a cycloneximide-sensitive inhibitor of death receptor signaling. Mol Cell Biol 2001;21:3964-73.
17. Evans CM, Beattie RM, Walker-Smith JA. Inflammatory bowel disease in childhood. In: Allan RN, Rhodes JM, Hanauer SB, et al, eds. In: Inflammatory bowel diseases, 3rd edn. New York: Churchill, Livingstone, 1997:647-70.
18. Cellier C, Patey N, Mauvieux L, et al. Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology 1998;114:471-81.
19. Kugathasan S, Willis J, Dahms BB, et al. Intrinsic hyperreactivity of mucosal T cells to interleukin-2 in pediatric Crohn's disease. J Pediatr 1198;133:675-99.
20. Mary JY, Modigliani R. Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Gut 1989;30:983-9.
21. D'Haens GR, Geboes K, Peeters M, et al. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 1998;114:262-7.
22. Juo P, Woo MS, Kuo CJ, et al. FADD is required for multiple signaling events downstream of the receptor Fas. Cell Growth Differ 1999;10:797-804.
23. Shimizu M, Fontana A, Takeda Y, et al. Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells. J Immunol 1999;162:7350-7.
24. Hanauer SB, Present DH. The state of the art in the management of inflammatory bowel disease. Rev Gastroenterol Disord 2003;3:81-92.
25. Liptay S, Bachem M, Hacker G, et al. Inhibition of nuclear factor kappa B and induction of apoptosis in T-lymphocytes by sulfasalazine. Br J Pharmacol 1999;128:1361-9.
26. Liptay S, Fulda S, Schanbacher M, et al. Molecular mechanisms of sulfasalazine-induced T-cell apoptosis. Br J Pharmacol 2002;137:608-20.
27. Peppercorn MA, Goldman P. Distribution studies of salicylazosulfapyridine and its metabolites. Gastroenterology 1973;64:240-5.
28. Daugas E, Susin SA, Zamzami N, et al. Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. FASEB J 2000;14:729-39.
29. Jurgensmeier JM, Xie Z, Deveraux Q, et al. Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci U S A 1998;95:4997-5002.
30. Tsujimoto Y. Role of Bcl-2 family proteins in apoptosis: apoptosomes or mitochondria? Genes Cells 1998;3:697-707.
31. Tiede I, Fritz G, Strand S, et al. CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+T lymphocytes. J Clin Invest 2003;111:1133-45.
32. Van den Brande JM, Braat H, van den Brink GR, et al. Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. Gastroenterology 2003;124:1774-85.
33. Lugering A, Schmidt M, Lugering N, et al. Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway. Gastroenterology 2001;121:1145-57.